WuXi Biologics Launches WuXia293 Platform for Manufacturing Difficult-to-Express Molecules
WuXi Biologics, a top global Contract Research, Development, and Manufacturing Organization (CRDMO), has unveiled a game-changing platform called WuXia293Stable. Built on HEK-293 cells, this innovative solution is designed to help scientists and manufacturers overcome long-standing challenges in producing tough-to-express biologic molecules. The launch shows that WuXi Biologics is firmly at the forefront of biotech innovation,…